Pharma Equity Group Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	102	115	233	440	-
Market Cap Growth	-40.71%	-50.84%	-46.98%	-	-
Enterprise Value	109	132	276	461	-
Last Close Price	0.08	0.09	0.19	0.43	-
PB Ratio	4.00	4.50	7.14	17.36	-
P/TBV Ratio	4.00	4.50	7.14	17.36	-
Debt / Equity Ratio	0.32	0.32	0.34	1.19	0.03
Net Debt / Equity Ratio	0.30	0.30	0.21	1.03	-0.12
Net Debt / EBITDA Ratio	-0.30	-0.30	-0.18	-1.04	0.20
Net Debt / FCF Ratio	-0.43	-0.43	-0.30	-1.56	0.27
Quick Ratio	0.45	0.45	0.76	0.26	2.38
Current Ratio	4.34	4.34	5.69	1.96	3.06
Return on Equity (ROE)	-87.28%	-87.28%	-139.99%	-110.06%	-
Return on Assets (ROA)	-35.79%	-35.79%	-39.98%	-35.06%	-
Return on Capital Employed (ROCE)	-84.10%	-84.10%	-91.90%	-74.90%	-58.70%
Earnings Yield	-24.91%	-22.14%	-17.41%	-5.54%	-
FCF Yield	-	-15.40%	-9.80%	-3.80%	-
Buyback Yield / Dilution	-14.02%	-14.02%	1.10%	-11.38%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.